万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>临床神经病学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>遗传学

NEUROGENETICS《神经遗传学》 (官网投稿)

简介
  • 期刊简称NEUROGENETICS
  • 参考译名《神经遗传学》
  • 核心类别 SCIE(2023版), 外文期刊,
  • IF影响因子
  • 自引率0.70%
  • 主要研究方向医学-CLINICAL NEUROLOGY临床神经病学;GENETICS & HEREDITY遗传学

主要研究方向:

等待设置主要研究方向
医学-CLINICAL NEUROLOGY临床神经病学;GENETICS & HEREDITY遗传学

NEUROGENETICS《神经遗传学》(季刊)。Neurogenetics publishes findings that contribute to a better understanding of the genetic basis of normal and abnor...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、官网网址:https://www.springer.com/journal/10048

3、投稿网址:https://www.editorialmanager.com/nege/

4、官网邮箱:auburger@em.uni-frankfurt.de(主编)

manuel@graeber.net(主编)

ljp@ucsf.edu(主编)

5、期刊刊期:季刊,逢季初月或季末月出版。

2021428日星期三

                            

 

投稿须知

【官网信息】

 

Submission guidelines

Instructions for Authors

Types of papers

Original Articles: There is no length limit or restriction on the number of illustrations/tables for full-length articles. However, authors are encouraged to avoid lengthy Introduction and Discussion sections. Original Articles should include the following sections after the title page and abstract: Introduction, Materials and Methods (subheadings allowed), Results (subheadings allowed), Discussion (subheadings allowed), Acknowledgements, References, Tables, Figure legends, and Appendices (if needed).Neurogenetics publishes associations of polymorphisms with complex conditions only if two independent cohorts (e.g., from different countries) of sufficient sizes have been investigated. In addition, the manuscript should be checked for compliance with the "Recommendations of the Working Group on Replication in Association Studies", Nature 447:655-660, 2007. Meta-analyses are welcome in principal, but will only be reviewed if they contain significant novel findings.In general, Neurogenetics does not publish negative results and new mutations in known disease genes unless the findings greatly advance knowledge on pathological mechanisms.

Review Articles: Review Articles and mini-reviews are most welcome. Contributors seeking to publish a review are nevertheless encouraged to contact an Editor prior to submitting the article.

Short Communications: Short Communications of up to 1,200 words (excluding references and abstract) should be submitted in the format of a short paper. The abstract should not comprise more than 100 words.

Letters to the Editors: This section is reserved for the publication of important preliminary novel findings and for the discussion of controversial issues. Letters should not exceed 500 words, one table or one figure, and 6 references.

Editorial Procedure

It is understood that by publishing a paper in Neurogenetics, the authors agree to make available to colleagues in academic (nonprofit) research any of the cells, nucleic acids, antibodies etc. that are not available from commercial suppliers and are required to substantiate the scientific conclusions of the paper. Neurogenetics does not publish negative results.

Neurogenetics publishes associations of polymorphisms with complex conditions only if two independent cohorts (e.g. from different countries) of sufficient sizes have been investigated. In addition, the manuscript should be checked for compliance with the recommendations of the NCI-NHGRI Working Group on Replication in Association Studies (see Nature [2007] 447: 655-660, DOI:10.1038/447655a).

Accession numbers and gene symbols

Authors should be aware that all new sequence information, including that which extends a previously determined sequence already present in the database (and which already has an accession number) must be submitted to any of the three major collaborative databases (DDBJ/EMBL/GenBank) for a new accession number. It is only necessary to submit to one database, without regard to where the sequence data will be published. Data is exchanged between DDBJ, EMBL and GenBank on a daily basis. The accession number must be provided before acceptance of the manuscript.

New genes and gene loci need to be designated by symbols in accordance with the Guidelines for Human Gene Nomenclature (http://www.gene.ucl.ac.uk/nomenclature/guidelines.html). To guarantee the designation of universally acceptable symbols, authors should consult the nomenclature committee by writing to nome@galton.ucl.ac.uk to have new names and symbols “approved” before publication.

Manuscript Submission

Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.

Permissions

Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.

Online Submission

Please follow the hyperlink “Submit manuscript” on the right and upload all of your manuscript files following the instructions given on the screen.

Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.

Specific Remark: Authors are asked to recommend names (with contact email) for 5-6 experts in the field that they feel would be good reviewers for this manuscript.

Title Page

Please make sure your title page contains the following information.

Title

The title should be concise and informative.

Author information

The name(s) of the author(s)

The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country

A clear indication and an active e-mail address of the corresponding author

If available, the 16-digit ORCID of the author(s)

If address information is provided with the affiliation(s) it will also be published.

For authors that are (temporarily) unaffiliated we will only capture their city and country of residence, not their e-mail address unless specifically requested.

Abstract

Please provide an abstract of 150 to 250 words. The abstract should not contain any undefined abbreviations or unspecified references.

For life science journals only (when applicable)

Trial registration number and date of registration

Trial registration number, date of registration followed by “retrospectively registered”

Keywords

Please provide 4 to 6 keywords which can be used for indexing purposes.

Declarations

All manuscripts must contain the following sections under the heading 'Declarations'.

If any of the sections are not relevant to your manuscript, please include the heading and write 'Not applicable' for that section.

To be used for all articles, including articles with biological applications

Funding (information that explains whether and by whom the research was supported)

Conflicts of interest/Competing interests (include appropriate disclosures)

Availability of data and material (data transparency)

Code availability (software application or custom code)

Authors' contributions (optional: please review the submission guidelines from the journal whether statements are mandatory)

Additional declarations for articles in life science journals that report the results of studies involving humans and/or animals

Ethics approval (include appropriate approvals or waivers)

Consent to participate (include appropriate statements)

Consent for publication (include appropriate statements)

Please see the relevant sections in the submission guidelines for further information as well as various examples of wording. Please revise/customize the sample statements according to your own needs.

Specific remarks

IntroductionThe Introduction should state the purpose of the investigation and give a short review of the pertinent literature.

Text

Text Formatting

Manuscripts should be submitted in Word.

Use a normal, plain font (e.g., 10-point Times Roman) for text.

Use italics for emphasis.

Use the automatic page numbering function to number the pages.

Do not use field functions.

Use tab stops or other commands for indents, not the space bar.

Use the table function, not spreadsheets, to make tables.

Use the equation editor or MathType for equations.

Save your file in docx format (Word 2007 or higher) or doc format (older Word versions).

Manuscripts with mathematical content can also be submitted in LaTeX.

LaTeX macro package (Download zip, 188 kB)

Headings

Please use no more than three levels of displayed headings.

Abbreviations

Abbreviations should be defined at first mention and used consistently thereafter.

Footnotes

Footnotes can be used to give additional information, which may include the citation of a reference included in the reference list. They should not consist solely of a reference citation, and they should never include the bibliographic details of a reference. They should also not contain any figures or tables.

Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data). Footnotes to the title or the authors of the article are not given reference symbols.

Always use footnotes instead of endnotes.

Acknowledgments

Acknowledgments of people, grants, funds, etc. should be placed in a separate section on the title page. The names of funding organizations should be written in full.

Scientific style

Please use the standard mathematical notation for formulae, symbols etc.:

Italic for single letters that denote mathematical constants, variables, and unknown quantities

Roman/upright for numerals, operators, and punctuation, and commonly defined functions or abbreviations, e.g., cos, det, e or exp, lim, log, max, min, sin, tan, d (for derivative)

Bold for vectors, tensors, and matrices.

Description of sequence variants and database submission

Manuscripts should be compatible with the HGVS rules to describe sequence variants (see the link below). If alternative nomenclature schemes exist in a specific field, they may be used in addition but not exclusively. Variants may be described using dbSNP identifiers but only when at least once a genomic description is given (format chr22.hg19:g.25855459G>A). All reference sequences used should be named using GenBank accession and version number.

HGVS rules

Authors are encouraged to check descriptions using software tools like the Mutalyzer program (see the link below).This journal supports the recommendations of the Human Variome Project. Prior to publication, authors are required to submit all variants and phenotypes described to a public database, e.g. the relevant gene variant database. Authors must confirm the status of database submission in their cover letter. In addition, authors must name in the manuscript the database(s) to which they will submit the variants and provide the URL.

Mutalyzer program

References

Citation

Reference citations in the text should be identified by numbers in square brackets. Some examples:

1. Negotiation research spans many disciplines [3].

2. This result was later contradicted by Becker and Seligman [5].

3. This effect has been widely studied [1-3, 7].

Reference list

The list of references should only include works that are cited in the text and that have been published or accepted for publication. Personal communications and unpublished works should only be mentioned in the text.

The entries in the list should be numbered consecutively.

If available, please always include DOIs as full DOI links in your reference list (e.g. “https://doi.org/abc”).

Journal article

Gamelin FX, Baquet G, Berthoin S, Thevenet D, Nourry C, Nottin S, Bosquet L (2009) Effect of high intensity intermittent training on heart rate variability in prepubescent children. Eur J Appl Physiol 105:731-738. https://doi.org/10.1007/s00421-008-0955-8

Ideally, the names of all authors should be provided, but the usage of “et al” in long author lists will also be accepted:

Smith J, Jones M Jr, Houghton L et al (1999) Future of health insurance. N Engl J Med 965:325–329

Article by DOI

Slifka MK, Whitton JL (2000) Clinical implications of dysregulated cytokine production. J Mol Med. https://doi.org/10.1007/s001090000086

Book

South J, Blass B (2001) The future of modern genomics. Blackwell, London

Book chapter

Brown B, Aaron M (2001) The politics of nature. In: Smith J (ed) The rise of modern genomics, 3rd edn. Wiley, New York, pp 230-257

Online document

Cartwright J (2007) Big stars have weather too. IOP Publishing PhysicsWeb. http://physicsweb.org/articles/news/11/6/16/1. Accessed 26 June 2007

Dissertation

Trent JW (1975) Experimental acute renal failure. Dissertation, University of California

Always use the standard abbreviation of a journal’s name according to the ISSN List of Title Word Abbreviations, see

……



  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭